|
시장보고서
상품코드
2051057
세균 세포 배양 시장 : 유형별, 제품별, 최종사용자별, 방법별, 지역별Bacterial Cell Culture Market, By Type, By Product, By End User, By Technique, By Region |
||||||
세균 세포 배양 시장은 2026년에 38억 달러로 추정되며, 2033년에 60억 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 6.9%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 38억 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간 CAGR: | 6.90% | 2033년 시장 규모 예측: | 60억 달러 |
세계 세균 세포 배양 시장은 생명공학 및 제약 산업에서 중요한 분야로 부상하고 있으며, 다양한 연구 개발 활동에서 매우 중요한 역할을 하고 있습니다. 세균 세포 배양은 백신, 항생제, 효소 및 기타 생명공학 제품 생산에 널리 활용되고 있습니다. 의료, 농업, 환경 부문의 발전에 기여하면서 이 시장의 중요성이 더욱 강조되고 있습니다. 효과적인 치료 솔루션과 지속가능한 생산 방식에 대한 수요가 지속적으로 증가함에 따라 세균 세포 배양 시장은 큰 폭의 성장이 예상됩니다. 이 기사에서는 세계 세균 세포 배양 시장의 주요 측면을 살펴보고 시장 역학, 성장 전망, 궤도에 영향을 미치는 요인을 탐구합니다.
시장 역학
세계 세균 세포 배양 시장은 감염성 질환의 확산, 백신 및 항생제 수요 증가, 생명공학 및 연구 부문에서 세균 세포 배양의 적용 확대 등 여러 요인에 의해 주도되고 있습니다. 특히 개발도상국에서의 세균 감염 발생률 증가는 효과적인 치료법의 필요성을 높이고, 세균 세포 배양 제품에 대한 수요를 촉진하고 있습니다. 또한, 제약회사 및 생명공학 기업의 연구개발 활동에 대한 투자 증가도 시장 성장을 더욱 촉진하고 있습니다. 그러나 시장에는 엄격한 규제 요건, 세포 배양 공정에 따른 높은 비용, 오염 위험과 같은 특정 제약도 존재합니다. 이러한 문제를 해결하기 위해서는 세균 세포 배양 기반 제품의 안전성, 유효성, 경제성을 보장하기 위해 기술과 생산 방법의 지속적인 발전이 필수적입니다. 이러한 제약에도 불구하고, 맞춤형 의료, 재생의료, 산업 바이오테크놀러지 등의 분야에서 세균 세포 배양 적용이 확대되면서 시장은 큰 성장 기회를 맞이하고 있습니다. 3D 세포배양 시스템, 일회용 바이오리액터와 같은 혁신적인 기술의 개발은 효율성, 확장성, 비용 효율성을 향상시켜 세균 세포 배양 시장에 혁명을 가져올 것으로 기대됩니다. 또한, 학계와 산업계 진입 기업과의 연계가 강화되면서 혁신이 촉진되고 새로운 세균 세포 배양 기반 제품의 상용화가 가속화되고 있습니다.
본 조사의 주요 특징:
- 이 보고서는 각 부문의 잠재적 수익기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 이 조사는 다음과 같은 매개 변수를 기반으로 세계 세균 세포 배양 시장의 주요 진입 기업을 프로파일링합니다. 구체적으로는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등입니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것으로 기대됩니다.
- 세계 세균 세포 배양 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 세균 세포 배양 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있습니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 세균 세포 배양 시장 : 유형별, 2021-2033년
제5장 세계의 세균 세포 배양 시장 : 제품별, 2021-2033년
제6장 세계의 세균 세포 배양 시장 : 최종사용자별, 2021-2033년
제7장 세계의 세균 세포 배양 시장 : 방법별, 2021-2033년
제8장 세계의 세균 세포 배양 시장 : 지역별, 2021-2033년
제9장 경쟁 구도
제10장 애널리스트의 제안
제11장 참고문헌과 조사 방법
KSM 26.06.16Bacterial Cell Culture Market is estimated to be valued at USD 3.80 Bn in 2026 and is expected to reach USD 6 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.9% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 3.80 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.90% | 2033 Value Projection: | USD 6 Bn |
The global bacterial cell culture market has emerged as a crucial segment within the biotechnology and pharmaceutical industries, playing a pivotal role in various research and development activities. Bacterial cell cultures are extensively utilized in the production of vaccines, antibiotics, enzymes, and other biotechnological products. The market's significance is underscored by its contribution to advancements in healthcare, agriculture, and environmental applications. As the demand for effective therapeutic solutions and sustainable production methods continues to rise, the bacterial cell culture market is poised for substantial growth. This article delves into the key aspects of the global bacterial cell culture market, exploring its market dynamics, growth prospects, and the factors influencing its trajectory.
Market Dynamics:
The global bacterial cell culture market is driven by several factors, including the increasing prevalence of infectious diseases, the growing demand for vaccines and antibiotics, and the expanding applications of bacterial cell cultures in biotechnology and research. The rising incidence of bacterial infections, particularly in developing countries, has fueled the need for effective treatment options, propelling the demand for bacterial cell culture-based products. Additionally, the increasing investment in research and development activities by pharmaceutical and biotechnology companies has further stimulated market growth. However, the market also faces certain restraints, such as stringent regulatory requirements, high costs associated with cell culture processes, and the risk of contamination. These challenges necessitate continuous advancements in technology and production methods to ensure the safety, efficacy, and affordability of bacterial cell culture-based products. Despite these restraints, the market presents significant opportunities for growth, driven by the expanding applications of bacterial cell cultures in fields such as personalized medicine, regenerative medicine, and industrial biotechnology. The development of innovative technologies, such as 3D cell culture systems and single-use bioreactors, is expected to revolutionize the bacterial cell culture market, offering enhanced efficiency, scalability, and cost-effectiveness. Moreover, increasing collaborations between academic institutions and industry players are fostering innovation and accelerating the commercialization of novel bacterial cell culture-based products.
Key Features of the Study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global bacterial cell culture market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Thermo Fisher Scientific, Merck KGaA, Becton, Dickinson and Company, Sigma-Aldrich (part of Merck), GE Healthcare, Corning Incorporated, Eppendorf AG, Lonza Group, Promega Corporation, Fujifilm Irvine Scientific, Sartorius AG, Bio-Rad Laboratories, MilliporeSigma, VWR International (part of Avantor), and BD Biosciences
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global bacterial cell culture market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bacterial cell culture market
Market Segmentation
- Type Insights (Revenue, USD Bn, 2021 - 2033)
- Prokaryotic Cell Culture
- Eukaryotic Cell Culture
- Product Insights (Revenue, USD Bn, 2021 - 2033)
- Media
- Reagents
- Equipment
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Biopharmaceutical Companies
- Academic & Research Institutes
- Contract Research Organizations (CROs)
- Clinical Laboratories
- Diagnostic Labs
- Technique Insights (Revenue, USD Bn, 2021 - 2033)
- Batch Culture
- Continuous Culture
- Fed-Batch Culture
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Thermo Fisher Scientific
- Merck KGaA
- Becton, Dickinson and Company
- Sigma-Aldrich (part of Merck)
- GE Healthcare
- Corning Incorporated
- Eppendorf AG
- Lonza Group
- Promega Corporation
- Fujifilm Irvine Scientific
- Sartorius AG
- Bio-Rad Laboratories
- MilliporeSigma
- VWR International (part of Avantor)
- BD Biosciences
Table of Contents
1. Research Objectives And Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Bacterial Cell Culture Market, By Type
- Global Bacterial Cell Culture Market, By Product
- Global Bacterial Cell Culture Market, By End User
- Global Bacterial Cell Culture Market, By Technique
- Global Bacterial Cell Culture Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Bacterial Cell Culture Market, By Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Prokaryotic Cell Culture
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Eukaryotic Cell Culture
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Bacterial Cell Culture Market, By Product, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Media
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Reagents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Equipment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Bacterial Cell Culture Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Academic & Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Clinical Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Diagnostic Labs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Bacterial Cell Culture Market, By Technique, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Batch Culture
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Continuous Culture
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Fed-Batch Culture
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Bacterial Cell Culture Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technique, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technique, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technique, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technique, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technique, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technique, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Becton, Dickinson and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sigma-Aldrich (part of Merck)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GE Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Corning Incorporated
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Eppendorf AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Lonza Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Promega Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Fujifilm Irvine Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sartorius AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio-Rad Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- MilliporeSigma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- VWR International (part of Avantor)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BD Biosciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us
